Unique ID issued by UMIN | UMIN000039487 |
---|---|
Receipt number | R000044975 |
Scientific Title | Search and verification test of genome and bio-markers for the purpose of constructing an individualized treatment algorithm for dementia and mild cognitive impairment |
Date of disclosure of the study information | 2020/03/01 |
Last modified on | 2023/09/15 17:16:04 |
Search and verification test of genome and bio-markers for the purpose of constructing an individualized treatment algorithm for dementia and mild cognitive impairment
Precision medicine research in dementia and mild cognitive impairment
Search and verification test of genome and bio-markers for the purpose of constructing an individualized treatment algorithm for dementia and mild cognitive impairment
Precision medicine research in dementia and mild cognitive impairment
Japan |
Major or Mild Neurocognitive Disorder Due to Alzheimer's Disease, Major or Mild Frontotemporal Neurocognitive Disorder, Major or Mild Neurocognitive Disorder with Lewy Bodies, Major or Mild Vascular Neurocognitive Disorder, Major or Mild Neurocognitive Disorder Due to Traumatic Brain Injury, Major or Mild Neurocognitive Disorder Due to Prion disease, Major or Mild Neurocognitive Disorder Due to Parkinson's Disease, Major or Mild Neurocognitive Disorder Due to Huntington's Disease, Major or Mild Neurocognitive Disorder Due to Multiple System Atrophy, Senile Dementia or Mild Cognitive Impairment of the Neurofibrillary Tangle Type, Major or Mild Neurocognitive Disorder Due to Normal Pressure Hydrocephalus, Cognitive Impairment Due to Delirium
Psychiatry |
Others
YES
It aims to create an individualized treatment algorithm in each dementia and mild cognitive impairment.
Safety,Efficacy
Exploratory
Cognitive Function Evaluation : Mini-Mental State Examination (MMSE)
NPI-Brief Questionnaire Form (NPI-Q)
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1. Person diagnosed with dementia or mild cognitive impairment with DSM-IV-TR or DSM-5
2. Person diagnosed with cognitive impairment due to delirium with DSM-IV-TR or DSM-5
3. Person whose age is 20 years old or older
4. Person who gained consent by free will with document
1. Person who cannot obtain consent from the person or his/her behalf
2. Person who is deemed ineligible by the principal investigator or sharing researcher
1120
1st name | Yuji |
Middle name | |
Last name | Murase |
Kansai Medical University
Department of Neuropsychiatry
570-8507
10-15 Fumizono-cho Moriguchi Osaka
06-6992-1001
murasey@takii.kmu.ac.jp
1st name | Yuji |
Middle name | |
Last name | Murase |
Kansai Medical University
Department of Neuropsychiatry
570-8507
10-15 Fumizono-cho Moriguchi Osaka
06-6992-1001
murasey@takii.kmu.ac.jp
Kansai Medical University
Mostly self-procurement
Ministry of education
Self funding
Kansai Medical University General Medical Center Ethics Review Committee
10-15 fumizono-cho, Moriguchi Osaka, 570-8507, Japan
06-6992-1001
yuji.mumu1983@gmail.com
NO
2020 | Year | 03 | Month | 01 | Day |
Unpublished
Open public recruiting
2020 | Year | 02 | Month | 14 | Day |
2020 | Year | 07 | Month | 16 | Day |
2020 | Year | 03 | Month | 01 | Day |
2025 | Year | 06 | Month | 30 | Day |
The aim of this study is precision medicine for dementia and mild cognitive impairment based on clinical background, genetic polymorphism, blood biomarkers such as inflammation-related factors and neuroplasticity-related factors, quantitative EEG of dementia and mild cognitive impairment.
2020 | Year | 02 | Month | 14 | Day |
2023 | Year | 09 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044975